Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids
NCT00048009
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Dual Integrin Antagonist
Sponsor
Hoffmann-La Roche